Target intelligence / Profile preview

Forkhead box P3 (FOXP3) (FOXP3)

Target
FOXP3
Molecular classification
Transcription factor, Forkhead box family
01

Overview

Forkhead box P3 (FOXP3) is a transcription factor that serves as the master regulator for the development and suppressive function of regulatory T cells (Tregs) (UniProt P63313). Primarily expressed in CD4+ T cells, FOXP3 is essential for maintaining immune homeostasis and self-tolerance by repressing the production of pro-inflammatory cytokines like IL-2 and upregulating suppressive markers such as CTLA-4 (Fontenot et al., 2003, PMID: 12612552). The FOXP3 locus is regulated by epigenetic modifications, specifically the methylation status of the Treg-specific demethylated region (TSDR), which determines the stability of the Treg lineage (Sakaguchi et al., 2007, PMID: 17200661). Mutations in the FOXP3 gene cause IPEX syndrome, a fatal multi-organ autoimmune disease, highlighting its critical role in preventing autoimmunity (NCBI Gene 50943). In cancer, FOXP3+ Tregs often accumulate in the tumor microenvironment, where they inhibit anti-tumor immunity and correlate with poor clinical outcomes. Therapeutic strategies include using low-dose IL-2 (Aldesleukin) or Sirolimus to expand FOXP3+ Tregs for treating autoimmune diseases and graft-versus-host disease, while research into FOXP3 inhibitors or Treg depletion is ongoing for cancer immunotherapy (Miyara et al., 2014, PMID: 25161031).

Other names
ScurfinIPEXJM2AIIDPIDXXPIDForkhead box protein P3
02

Mechanism of action

Transcriptional regulation of genes involved in regulatory T cell function and stabilization of the Treg phenotype.

03

Biological functions

Immune responseT-cell differentiationImmune toleranceRegulation of gene expression
04

Disease associations

Autoimmune diseaseCancerInflammationGraft-versus-host disease
05

Safety considerations

Systemic immunosuppressionAutoimmunityRisk of tumor progressionCytokine release syndrome
06

Interacting drugs

Aldesleukin

4 more in the full profile.

07

Biomarkers

FOXP3 expression levelsCD4+CD25+FOXP3+ T-cell frequencyTreg-specific demethylated region (TSDR) methylation status

Beyond the preview

Go deeper on Forkhead box P3 (FOXP3) (FOXP3).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Forkhead box P3 (FOXP3) (FOXP3).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call